A step closer to meeting the threat of avian influenza

被引:4
作者
Schultz-Cherry, Stacey [1 ]
McCullers, Jonathan A.
机构
[1] Univ Wisconsin, Dept Med Microbiol & Immunol, Madison, WI 53706 USA
[2] St Jude Childrens Hosp, Dept Infect Dis, Memphis, TN 38105 USA
来源
PLOS MEDICINE | 2006年 / 3卷 / 09期
关键词
D O I
10.1371/journal.pmed.0030375
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1463 / 1464
页数:2
相关论文
共 13 条
[1]   Current concepts - Avian influenza A (H5N1) infection in humans [J].
Beigel, H ;
Farrar, H ;
Han, AM ;
Hayden, FG ;
Hyer, R ;
de Jong, MD ;
Lochindarat, S ;
Tien, NTK ;
Hien, NT ;
Hien, TT ;
Nicoll, A ;
Touch, S ;
Yuen, KY .
NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (13) :1374-1385
[2]   Safety, efficacy and effectiveness of cold-adapted, live, attenuated, trivalent, intranasal influenza vaccine in adults and children [J].
Belshe, RB ;
Gruber, WC .
PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY OF LONDON SERIES B-BIOLOGICAL SCIENCES, 2001, 356 (1416) :1947-1951
[3]   Generation and characterization of a cold-adapted influenza A H9N2 reassortant as a live pandemic influenza virus vaccine candidate [J].
Chen, H ;
Matsuoka, Y ;
Swayne, D ;
Chen, Q ;
Cox, NJ ;
Murphy, BR ;
Subbarao, K .
VACCINE, 2003, 21 (27-30) :4430-4436
[4]   Recombinant influenza A virus vaccines for the pathogenic human A Hong Kong 97 (H5N1) viruses [J].
Li, SQ ;
Liu, CG ;
Klimov, A ;
Subbarao, K ;
Perdue, ML ;
Mo, D ;
Ji, YY ;
Woods, L ;
Hietala, S ;
Bryant, M .
JOURNAL OF INFECTIOUS DISEASES, 1999, 179 (05) :1132-1138
[5]   Principles underlying the development and use of live attenuated cold-adapted influenza A and B virus vaccines [J].
Murphy, BR ;
Coelingh, K .
VIRAL IMMUNOLOGY, 2002, 15 (02) :295-323
[6]   Safety and antigenicity of non-adjuvanted and MF59-adjuvanted influenza A/Duck/Singapore/97 (H5N3) vaccine: a randomised trial of two potential vaccines against H5N1 influenza [J].
Nicholson, KG ;
Colegate, AE ;
Podda, A ;
Stephenson, I ;
Wood, J ;
Ypma, E ;
Zambon, MC .
LANCET, 2001, 357 (9272) :1937-1943
[7]   Making better influenza virus vaccines? [J].
Palese, P .
EMERGING INFECTIOUS DISEASES, 2006, 12 (01) :61-65
[8]   Evaluation of a genetically modified reassortant H5N1 influenza A virus vaccine candidate generated by plasmid-based reverse genetics [J].
Subbarao, K ;
Chen, HL ;
Swayne, D ;
Mingay, L ;
Fodor, E ;
Brownlee, G ;
Xu, XY ;
Lu, XH ;
Katz, J ;
Cox, N ;
Matsuoka, Y .
VIROLOGY, 2003, 305 (01) :192-200
[9]   Live, attenuated influenza A H5N1 candidate vaccines provide broad cross-protection in mice and ferrets [J].
Suguitan, Amorsolo L., Jr. ;
McAuliffe, Josephine ;
Mills, Kimberly L. ;
Jin, Hong ;
Duke, Greg ;
Lu, Bin ;
Luke, Catherine J. ;
Murphy, Brian ;
Swayne, David E. ;
Kemble, George ;
Subbarao, Kanta .
PLOS MEDICINE, 2006, 3 (09) :1541-1555
[10]   Safety and immunogenicity of an inactivated subvirion influenza A (H5N1) vaccine [J].
Treanor, JJ ;
Campbell, JD ;
Zangwill, KM ;
Rowe, T ;
Wolff, M .
NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (13) :1343-1351